Clifford Swan Investment Counsel’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $93K | Hold |
|
|||||
|
2021
Q2 | $101K | Hold |
|
|||||
|
2021
Q1 | $117K | Hold |
|
|||||
|
2020
Q4 | $97K | Sell |
|
|||||
|
2020
Q3 | $117K | Sell |
|
|||||
|
2020
Q2 | $166K | Buy |
|
|||||
|
2020
Q1 | $117K | Hold |
|
|||||
|
2019
Q4 | $127K | Sell |
|
|||||
|
2019
Q3 | $102K | Sell |
|
|||||
|
2019
Q2 | $1.11M | Buy |
|
|||||
|
2019
Q1 | $1.89M | Sell |
|
|||||
|
2018
Q4 | $1.97M | Sell |
|
|||||
|
2018
Q3 | $2.85M | Sell |
|
|||||
|
2018
Q2 | $3.23M | Sell |
|
|||||
|
2018
Q1 | $2.34M | Sell |
|
|||||
|
2017
Q4 | $2.97M | Sell |
|
|||||
|
2017
Q3 | $3.9M | Sell |
|
|||||
|
2017
Q2 | $7.62M | Buy |
|
|||||
|
2017
Q1 | $5.53M | Buy |
|
|||||
|
2016
Q4 | $4.09M | Buy |
|
|||||
|
2016
Q3 | $2.54M | Sell |
|
|||||
|
2016
Q2 | $2.82M | Buy |
|
|||||
|
2016
Q1 | $1.82M | Buy |
|
|||||
|
2015
Q4 | $2.2M | Buy |
|
|||||
|
2015
Q3 | $1.89M | Sell |
|
|||||
|
2015
Q2 | $2.59M | Sell |
|
|||||
|
2015
Q1 | $3.86M | Hold |
|
|||||
|
2014
Q4 | $3.56M | Sell |
|
|||||
|
2014
Q3 | $4.09M | Sell |
|
|||||
|
2014
Q2 | $4.94M | Sell |
|
|||||
|
2014
Q1 | $6.59M | Sell |
|
|||||
|
2013
Q4 | $6.2M | Sell |
|
|||||
|
2013
Q3 | $5.98M | Buy |
|
|||||
|
2013
Q2 | $5.92M | Buy |
|